Chromogranins A B
Chromogranins A B - Related Videos
07:48
Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds
0 Views •
Cited by 9 •
2021
This paper lists the steps required to seed neuroblastoma cell lines on previously described three-dimensional collagen-based scaffolds, maintain cell growth for a predetermined timeframe, and retrieve scaffolds for several cell growth and cell behavior analyses and downstream applications, adaptable to satisfy a range of experimental aims.
13:42
Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
0 Views •
Cited by 3 •
2013
The presented method offers a way to detect functional effective cardiotropic autoantibodies in the plasma of patients with dilated cardiomyopathy, irrespective of the specific antigen, by analysing the impact of isolated patient immunoglobulin on cellular shortening and intracellular calcium transients in isolated rat cardiomyocytes.
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
0 Views •
Cited by 10 •
2019
Neurospheres grown as 3D cultures constitute a powerful tool to study glioma biology. Here we present a protocol to perform immunohistochemistry while maintaining the 3D structure of glioma neurospheres through paraffin embedding. This method enables the characterization of glioma neurosphere properties such as stemness and neural differentiation.
07:12
Profiling Maternal Behavior Responses During Whole-Brain Imaging
0 Views •
2025
Presented here is a video analysis pipeline that overcomes challenges in behavioral monitoring within MRI environments, allowing for the detection of uninstructed behavioral responses to external cues. This analysis will facilitate a more comprehensive understanding of evoked internal state changes and brain-wide activity.
07:34
Manipulation of Rhythmic Food Intake in Mice Using a Custom-Made Feeding System
0 Views •
2022
Restricting the timing of food intake has emerged as a promising intervention to attenuate diet-induced metabolic diseases. This manuscript details the construction and use of an efficient system built in-house for measuring and manipulating rhythmic food intake in mice.
FAQs
Their acidic, aggregation-prone regions promote the concentration and organization of hormones and neuropeptides within secretory granules. This packaging step helps neuroendocrine cells and neurons retain signaling molecules before stimulation. By organizing this cargo in a granule environment, chromogranins contribute to the readiness of stored molecules for later regulated release.
Proteolytic processing cleaves chromogranins into smaller biologically active peptides. These products extend chromogranin function beyond structural organization because they can influence secretion as well as vascular and immune responses. Consequently, chromogranin activity depends not only on the intact proteins stored in granules, but also on how their processed peptides participate in signaling.
Chromogranins help connect stored secretory cargo with the regulated exocytosis of neuroendocrine cells and neurons. Their participation in granule organization supports the controlled release of hormones and neuropeptides rather than indiscriminate discharge. Studying this relationship helps explain how cells coordinate intracellular storage with signal-dependent secretion in biological systems.
Because these proteins are associated with secretory granules and generate signaling peptides through processing, they provide multiple readouts of neuroendocrine cell function. Their study can reveal how cells package peptide cargo, regulate secretion, and produce downstream vascular or immune effects. This makes them relevant to broader investigations of peptide hormone biology and cellular communication.
Chromogranin A measurements can serve as supportive biomarkers when some neuroendocrine tumors are being evaluated. The result contributes biological information about neuroendocrine activity, but it is not presented as a stand-alone determination. Its value is greatest when considered alongside the broader clinical and investigative context rather than interpreted in isolation.
Medication exposure and other clinical conditions can influence chromogranin A measurements, so an abnormal value may not reflect a neuroendocrine tumor alone. Interpretation therefore requires attention to factors that may alter the measurement and to the purpose of testing. This limitation is why chromogranin A functions as a supportive, rather than definitive, biomarker.